Reassessing Metformin's Survival Advantage
Peter discusses a paper that challenges the notion of a survival advantage for type two diabetics treated with metformin. He explains the mechanism of metformin and its debated role in gero protection.In this clip
From this podcast
The Peter Attia Drive Podcast
270 ‒ Journal club with Andrew Huberman: metformin, power of belief, & how to read scientific papers
Related Questions